| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| DGX | 67.30% | $19.26B | +24.67% | 2.22% |
| A | 56.61% | $34.37B | -3.52% | 0.81% |
| TECH | 56.07% | $8.26B | -26.10% | 0.61% |
| IQV | 55.80% | $28.45B | -22.80% | 0.00% |
| CIGI | 54.12% | $6.63B | +15.14% | 0.23% |
| RVTY | 52.95% | $11.86B | -3.22% | 0.28% |
| ITW | 52.94% | $75.56B | +10.19% | 2.32% |
| AVB | 52.81% | $28.68B | -1.15% | 3.42% |
| SLGN | 52.74% | $6.05B | +33.60% | 1.40% |
| MIDD | 52.59% | $7.92B | +23.36% | 0.00% |
| WAT | 52.44% | $20.70B | +22.90% | 0.00% |
| STE | 52.35% | $22.88B | +8.93% | 0.98% |
| MTD | 51.85% | $25.08B | -7.76% | 0.00% |
| ECL | 51.81% | $76.24B | +11.00% | 0.94% |
| TMO | 51.59% | $160.88B | -19.87% | 0.39% |
| AFL | 51.30% | $55.82B | +16.09% | 2.10% |
| PRI | 51.27% | $8.96B | +16.88% | 1.41% |
| CRL | 50.97% | $7.78B | -21.53% | 0.00% |
| SYK | 50.87% | $148.85B | +16.07% | 0.85% |
| LIN | 50.40% | $221.22B | +8.99% | 1.22% |
Current Value
$260.011 Year Return
Current Value
$260.011 Year Return
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| FXH | 70.35% | $899.37M | 0.62% |
| RSPH | 70.03% | $726.61M | 0.4% |
| FHLC | 64.61% | $2.45B | 0.084% |
| VHT | 64.23% | $15.43B | 0.09% |
| IYH | 63.88% | $2.74B | 0.39% |
| XLV | 62.94% | $34.49B | 0.09% |
| FVD | 61.53% | $9.12B | 0.61% |
| IXJ | 61.45% | $3.76B | 0.41% |
| NOBL | 60.96% | $11.56B | 0.35% |
| KNG | 60.62% | $3.84B | 0.75% |
| LGLV | 60.04% | $1.10B | 0.12% |
| SDY | 59.95% | $20.40B | 0.35% |
| VOOV | 59.93% | $5.57B | 0.1% |
| DGRO | 59.91% | $32.65B | 0.08% |
| SPYV | 59.83% | $27.03B | 0.04% |
| IVE | 59.67% | $39.79B | 0.18% |
| XHE | 59.59% | $167.96M | 0.35% |
| IUSV | 59.46% | $21.31B | 0.04% |
| VOE | 59.43% | $18.18B | 0.07% |
| NUMV | 59.31% | $382.63M | 0.31% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TAIL | -36.37% | $95.09M | 0.59% |
| VIXY | -36.13% | $185.99M | 0.85% |
| IVOL | -23.00% | $342.02M | 1.02% |
| BTAL | -18.63% | $312.42M | 1.43% |
| TPMN | -16.77% | $30.94M | 0.65% |
| CLIP | -14.40% | $1.54B | 0.07% |
| SHYM | -11.74% | $355.63M | 0.35% |
| CTA | -10.90% | $1.06B | 0.76% |
| FTSD | -10.57% | $233.04M | 0.25% |
| FXY | -9.03% | $812.67M | 0.4% |
| FXE | -7.37% | $585.58M | 0.4% |
| CANE | -7.17% | $11.26M | 0.29% |
| FMF | -6.57% | $157.92M | 0.95% |
| BIL | -5.95% | $41.97B | 0.1356% |
| ULST | -5.76% | $595.49M | 0.2% |
| GBIL | -5.26% | $6.35B | 0.12% |
| AGZD | -5.21% | $98.49M | 0.23% |
| TFLO | -4.81% | $6.74B | 0.15% |
| XONE | -4.06% | $627.68M | 0.03% |
| KCCA | -3.88% | $108.82M | 0.87% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| LTM | -0.01% | $12.62B | -95.43% | 2.40% |
| SAND | 0.05% | $2.86B | +74.73% | 0.59% |
| PHYS | -0.13% | - | - | 0.00% |
| CIG.C | -0.14% | $2.65B | +23.47% | 0.00% |
| GHG | 0.15% | $151.48M | -7.01% | 0.00% |
| EQX | -0.16% | $4.46B | +1.03% | 0.00% |
| UUUU | -0.31% | $1.26B | -4.27% | 0.00% |
| SVM | 0.39% | $1.01B | +32.10% | 0.54% |
| NEUE | -0.43% | $60.98M | +32.62% | 0.00% |
| ATEC | -0.50% | $1.70B | +7.01% | 0.00% |
| CNK | -0.58% | $3.52B | +41.39% | 0.53% |
| UEC | -0.64% | $2.81B | +5.16% | 0.00% |
| IMDX | -0.65% | $83.22M | -2.68% | 0.00% |
| SSRM | -0.79% | $2.49B | +166.96% | 0.00% |
| CRVO | 0.79% | $54.87M | -58.71% | 0.00% |
| CARV | 0.91% | $8.88M | +17.45% | 0.00% |
| AIFU | 0.97% | $15.34M | +65.63% | 0.00% |
| RLX | -1.01% | $2.07B | +25.27% | 0.44% |
| UUU | -1.08% | $8.42M | +150.90% | 0.00% |
| GFI | -1.19% | $20.91B | +50.71% | 2.38% |
Yahoo
Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced the appointment of Prasanth Reddy, M.D. MPH, FACP, as its Chief Medical Officer. Dr. Reddy brings critical experience in precision oncology, product development, and patient access, and will play a pivotal role in advancing Mercy's mission to save lives and relieve suffering through early cancer detection.
Yahoo
Berberian brings significant technology leadership and cybersecurity expertiseARLINGTON, Va., July 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Lance V. Berberian to its Board of Directors, effective July 15, 2025. He has also been named a member of the Audit Committee of the Board. Following the appointment of Mr. Berberian, the Board will comprise 10 directors. “We are excited to welcome Lance to our Board of Directors,” said David King, Ch
MarketWatch
Labcorp Holdings Inc. stock underperforms Monday when compared to competitors
Finnhub
On June 5, 2025, in an 8-1 decision, the Supreme Court dismissed Laboratory Corporation of America Holdings v. Davis as improvidently granted—despite having already granted certiorari and heard oral...
Yahoo
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
MarketWatch
Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BSMW | 0.03% | $107.54M | 0.18% |
| SPTS | -0.03% | $5.77B | 0.03% |
| STPZ | -0.29% | $443.02M | 0.2% |
| WEAT | 0.60% | $124.20M | 0.28% |
| USDU | 0.74% | $124.09M | 0.5% |
| GLDM | 0.82% | $15.92B | 0.1% |
| UTWO | 0.89% | $376.38M | 0.15% |
| CORN | -1.16% | $45.73M | 0.2% |
| SGOL | 1.19% | $5.24B | 0.17% |
| VGSH | 1.20% | $22.64B | 0.03% |
| IAU | 1.22% | $47.38B | 0.25% |
| FXC | 1.37% | $93.54M | 0.4% |
| OUNZ | 1.37% | $1.74B | 0.25% |
| BAR | 1.39% | $1.12B | 0.1749% |
| GLD | 1.44% | $101.49B | 0.4% |
| AAAU | 1.51% | $1.57B | 0.18% |
| BOXX | -1.52% | $6.85B | 0.19% |
| XHLF | -1.56% | $1.73B | 0.03% |
| BILS | -1.72% | $3.80B | 0.1356% |
| KMLM | -1.72% | $184.66M | 0.9% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| LITB | -9.38% | $23.17M | -74.54% | 0.00% |
| MVO | -8.03% | $67.62M | -36.43% | 21.27% |
| CPSH | -6.37% | $38.93M | +59.05% | 0.00% |
| ZCMD | -4.86% | $30.81M | +2.52% | 0.00% |
| ALXO | -4.00% | $24.51M | -92.79% | 0.00% |
| HUSA | -3.68% | $18.72M | -18.25% | 0.00% |
| CYCN | -3.58% | $10.08M | +36.52% | 0.00% |
| SRRK | -3.54% | $3.25B | +334.52% | 0.00% |
| DFDV | -3.39% | $298.06M | +2,070.86% | 0.00% |
| VSTA | -3.13% | $332.04M | +38.00% | 0.00% |
| VSA | -3.08% | $8.76M | -15.57% | 0.00% |
| CREG | -2.63% | $5.71M | -76.86% | 0.00% |
| OR | -1.96% | $4.84B | +62.23% | 0.75% |
| STG | -1.71% | $31.09M | -22.74% | 0.00% |
| AEM | -1.66% | $58.71B | +65.44% | 1.38% |
| KROS | -1.27% | $564.96M | -67.45% | 0.00% |
| FYBR | -1.25% | $9.15B | +43.24% | 0.00% |
| GFI | -1.19% | $20.91B | +50.71% | 2.38% |
| UUU | -1.08% | $8.42M | +150.90% | 0.00% |
| RLX | -1.01% | $2.07B | +25.27% | 0.44% |
Double maintains 8 strategies that include LH - Labcorp Holdings, Inc.
